{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:24:45Z","timestamp":1740147885835,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12149-024-01983-9","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T20:11:43Z","timestamp":1727554303000},"page":"158-166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["18F-FDG PET\/CT biomarkers as predictors of long term outcomes and survival rates in patients with high risk malignant pulmonary masses\/nodules treated with stereotactic ablative radiotherapy"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4861-619X","authenticated-orcid":false,"given":"Raef R.","family":"Boktor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore U.","family":"Berlangieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eddie","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeline","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia J.","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"key":"1983_CR1","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.ijrobp.2009.07.1751","volume":"81","author":"H Onishi","year":"2010","unstructured":"Onishi H, Shirato H, Nagata Y, et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys. 2010;81:1352\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1983_CR2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ijrobp.2007.10.053","volume":"70","author":"FJ Lagerwaard","year":"2008","unstructured":"Lagerwaard FJ, Haasbeek CJ, Smit EF, et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;70:685\u201392.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1983_CR3","first-page":"S278","volume":"6","author":"FJ Lagerwaard","year":"2011","unstructured":"Lagerwaard FJ, Verstegen NE, Haasbeek CJ, et al. Stereotactic ablative radiotherapy (SABR) in potentially operable stage I non-small cell lung cancer patients. J Thorac Oncol. 2011;6:S278\u20139.","journal-title":"J Thorac Oncol"},{"key":"1983_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1095-0397(99)00016-3","volume":"2","author":"SM Larson","year":"1999","unstructured":"Larson SM, Erdi Y, Akhurst T, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using 18F-FDG PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging. 1999;2:159\u201371.","journal-title":"Clin Positron Imaging."},{"issue":"3","key":"1983_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.radonc.2008.06.014","volume":"89","author":"JB Roedl","year":"2009","unstructured":"Roedl JB, Colen RR, Holalkere NS, et al. Adenocarcinomas of the esophagus: response to chemo-radiotherapy is associated with decrease of metabolic tumor volume as measured on 18F-FDG PET-CT. Comparison to histopathologic and clinical response evaluation. Radiother Oncol. 2009;89(3):278\u201386.","journal-title":"Radiother Oncol."},{"issue":"10","key":"1983_CR6","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2967\/jnumed.108.053694","volume":"49","author":"MR Benz","year":"2008","unstructured":"Benz MR, Allen-Auerbach MS, Eilber FC, et al. Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomas. J Nucl Med. 2008;49(10):1579\u201384.","journal-title":"J Nucl Med."},{"key":"1983_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijrobp.2003.10.045","volume":"59","author":"AC Paulino","year":"2004","unstructured":"Paulino AC, Johnstone PA. 18F-FDG PET in radiotherapy treatment planning: Pandora\u2019s box? Int J Radiat Oncol Biol Phys. 2004;59:4\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1983_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00259-014-2903-7","volume":"42","author":"HJ Im","year":"2015","unstructured":"Im HJ, Pak K, Cheon GJ, et al. Prognostic value of volumetric parameters of 18F-FDG PET in non-small-cell lung cancer: a meta-analysis. Eur J Nucl Med Mol Imaging. 2015;42:241\u201351.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1983_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00259-011-1936-4","volume":"39","author":"HJ Im","year":"2012","unstructured":"Im HJ, Kim TS, Park SY, et al. Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG 18F-FDG PET\/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma. Eur J Nucl Med Mol Imaging. 2012;39:39\u201349.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1983_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s13139-012-0181-5","volume":"47","author":"HJ Im","year":"2013","unstructured":"Im HJ, Kim YK, Kim YI, Lee JJ, Lee WW, Kim SE. Usefulness of combined metabolic-volumetric indices of 18F-FDG PET\/CT for the early prediction of neoadjuvant chemotherapy outcomes in breast cancer. Nucl Med Mol Imaging. 2013;47:36\u201343.","journal-title":"Nucl Med Mol Imaging"},{"key":"1983_CR11","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/j.1541-0420.2008.00995.x","volume":"64","author":"T Hothorn","year":"2008","unstructured":"Hothorn T, Zeileis A. Generalized maximally selected statistics. Biometrics. 2008;64:1263\u20139. https:\/\/doi.org\/10.1111\/j.1541-0420.2008.00995.x.","journal-title":"Biometrics"},{"key":"1983_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/1754-9485.12805","volume":"63","author":"K Nie","year":"2019","unstructured":"Nie K, Zhang Y, Nie W, Zhu L, Chen Y, et al. Prognostic value of metabolic tumour volume and total lesion glycolysis measured by 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in small cell lung cancer: a systematic review and meta-analysis. J Med Imaging Radiat Oncol. 2019;63:84\u201393.","journal-title":"J Med Imaging Radiat Oncol."},{"issue":"1","key":"1983_CR13","first-page":"3","volume":"39","author":"A Yanarates","year":"2020","unstructured":"Yanarates A, Yazici B. Volumetric 18F-FDG PET parameters can predict overall survival in advanced lung adenocarcinoma. Rev Esp Med Nucl Imagen Mol. 2020;39(1):3\u20138.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"1983_CR14","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1016\/j.ejrad.2012.07.009","volume":"81","author":"Y Zaizena","year":"2012","unstructured":"Zaizena Y, Azuma K, Kurata S, Sadashima E, Hattori S, et al. Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy. Eur J Radiol. 2012;81:4179\u201384.","journal-title":"Eur J Radiol"},{"key":"1983_CR15","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/crj.12391","volume":"11","author":"F Y\u0131ld\u0131r\u0131m","year":"2017","unstructured":"Y\u0131ld\u0131r\u0131m F, Yurdakul AS, \u00d6zkaya S, Akdemir \u00dc\u00d6, \u00d6zt\u00fcrk C. Total lesion glycolysis by 18F-FDG PET\/CT is independent prognostic factor in patients with advanced non-small cell lung cancer. Clin Respir J. 2017;11:602\u201311.","journal-title":"Clin Respir J"},{"issue":"1","key":"1983_CR16","first-page":"9","volume":"39","author":"Emine Budaka","year":"2020","unstructured":"Budaka Emine, et al. The prognostic role of 18F-FDG PET\/CT in small-cell lung cancer. Rev Esp Med Nucl Imagen Mol. 2020;39(1):9\u201313.","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"1983_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.lungcan.2010.04.004","volume":"71","author":"Y Imamura","year":"2011","unstructured":"Imamura Y, Azuma K, Kurata S, Hattori S, Sasada T, Kinoshita T, et al. Prognostic value of SUVmax measurements obtained by 18F-FDG PET in patients with non-small cell lung cancer receiving chemotherapy. Lung Cancer. 2011;71:49\u201354.","journal-title":"Lung Cancer"},{"key":"1983_CR18","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1515\/raon-2015-0043","volume":"49","author":"A Nappi","year":"2015","unstructured":"Nappi A, Gallicchio R, Simeon V, Nardelli A, Pelagalli A, Zupa A, et al. 18F-FDG PET\/CT parameters as predictors of outcome in inoperable NSCLC patients. Radiol Oncol. 2015;49:320\u20136.","journal-title":"Radiol Oncol"},{"key":"1983_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/RLU.0000000000000740","volume":"40","author":"E Kurtipek","year":"2015","unstructured":"Kurtipek E, Ayci MCY, D\u00fczg\u00fcn N, Esme H, Terzi Y, Bakdik S, et al. 18F-FDG PET\/CT mean SUV and metabolic tumor volume for mean survival time in non\u2013small cell lung cancer. Clin Nucl Med. 2015;40:459\u201363.","journal-title":"Clin Nucl Med."},{"issue":"449\u201354","key":"1983_CR20","first-page":"29","volume":"64","author":"K Basaki","year":"2006","unstructured":"Basaki K, Abe Y, Aoki M, Kondo H, Hatayama Y, Nakaji S. Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: impact of tumor volume. Int J Radiat Oncol Biol Phys. 2006;64(449\u201354):29.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"1983_CR21","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/JTO.0b013e3181d2dcd9","volume":"5","author":"T Kawaguchi","year":"2010","unstructured":"Kawaguchi T, Takada M, Kubo A, Matsumura A, Fukai S, Tamura A, et al. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957patients with NSCLC. J Thorac Oncol. 2010;5:620\u201330.","journal-title":"J Thorac Oncol"},{"issue":"1163\u201381","key":"1983_CR22","first-page":"31","volume":"30","author":"SJ UyBico","year":"2010","unstructured":"UyBico SJ, Wu CC, Suh RD, Le NH, Brown K, Krishnam MS. Lung cancer staging essentials: the new TNM staging system and potential imaging pitfalls. Radio-graphics. 2010;30(1163\u201381):31.","journal-title":"Radio-graphics."},{"key":"1983_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s13139-012-0165-5","volume":"46","author":"SW Yoo","year":"2012","unstructured":"Yoo SW, Kim J, Chong A, Kwon SY, Min JJ, Song HC, et al. Metabolic tumor volume measured by 18F-FDG PET\/ CT can further stratify the prognosis of patients with stage IV non-small cell lung cancer. Nucl Med Mol Imaging. 2012;46:286\u201393.","journal-title":"Nucl Med Mol Imaging"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-024-01983-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-024-01983-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-024-01983-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T08:51:24Z","timestamp":1738745484000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-024-01983-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1983"],"URL":"https:\/\/doi.org\/10.1007\/s12149-024-01983-9","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"type":"print","value":"0914-7187"},{"type":"electronic","value":"1864-6433"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"19 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics approval has been obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}